Epithelial–Mesenchymal Transition in Cutaneous Fibrosis Disease: From Mechanisms to Therapy

    June 2026 in “ Frontiers in Immunology ”
    Shaoxiang Yuan, Ziyi Luo, Nina Yang … Chengliang Deng
    Studysummary This review discusses the role of epithelial–mesenchymal transition in cutaneous fibrotic disorders and highlights potential molecular targets for therapy, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on frontiersin.org →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Clinical, Mechanistic, and Therapeutic Landscape of Cutaneous Fibrosis Science Translational Medicine · 2024
    2. WNT5A Drives Interleukin-6-Dependent Epithelial-Mesenchymal Transition via the JAK/STAT Pathway in Keloid Pathogenesis Burns & Trauma · 2022
    3. The Dynamics of the Skin’s Immune System International Journal of Molecular Sciences · 2019
    4. The Significance of Notch Pathway in the Development of Fibrosis in Systemic Sclerosis Annals of Dermatology · 2019
    5. Epithelial-To-Mesenchymal Transition in Cutaneous Wound Healing: Where We Are and Where We Are Heading Developmental Dynamics · 2017
    6. Epithelial–Mesenchymal Transition in Keloid Tissues and TGF-β1–Induced Hair Follicle Outer Root Sheath Keratinocytes Wound repair and regeneration · 2015